Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best. THE OPPORTUNITY Vir Bio is looking for a Director, Translational Biomarkers to drive biomarker strategy across our pipeline, from preclinical discovery through clinical development. Reporting to the VP, Translational Biology, you will translate complex immunologic and molecular insights into actionable plans that inform mechanism of action, dose selection, patient selection, and clinical outcomes in immune-oncology and related disease areas. You will lead biomarker design and execution for key programs, oversee advanced translational assays in both preclinical models and human samples, and partner closely with discovery, clinical, data science, and external collaborators to deliver high-quality biomarker data. You will manage scientists, contribute to regulatory filings, and help build the infrastructure and partnerships needed to advance cutting-edge biomarker science. This role is located in our San Francisco headquarters with an expectation of at least 3 days per week in office.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree